Although much evidence circumstantially implicates the brain cholinergic system in Alzheimer's disease (AD) dementia, the degree to which the cholinergic dysfunction can explain the features of the cognitive impairment is not known. We propose that examination of non-AD individuals also having brain cholinergic dysfunction is likely to significantly increase our understanding of the role of the brain cholinergic system in dementia. In this regard our MAJOR OBJECTIVE is to conduct a combined brain neurochemical, neuropathological, and behavioral study of 31 individuals from four well-studied families afflicted with a hereditary cerebellar disorder (dominantly-inherited olivopontocerebellar atrophy, OPCA). A preliminary neurochemical study of several members of each family revealed a cortical cholinergic deficiency as severe as that observed in end-stage AD. Surprisingly, none of the OPCA patients at last examination appeared grossly to have any clinically significant dementia.
Our SPECIFIC AIMS are: 1) to assess carefully, once a year the cognitive (using a test battery approach) and neurological status of the 31 affected patients; 2) to examine systematically and extensively the behavioral of the major neurotrasnmitter systems (esp. cholinergic) in brain of the OPCA patients as they come to autopsy; and 3) to perform the first detailed neuropathological examination of extracerebellar brain areas in OPCA with special attention devoted to the quantitative assessment of the basal forebrain cholinergic nuclei. As shown below, all personnel have demonstrated expertise in their individual areas of research. An essential and special feature of this proposal will be the collaboration with Drs. Schut and Currier, who will arrange all patient contact with the investigators. Much effort is now being directed to the pharmacological restoration of cholinergic function in AD brain in an attempt to normalize cognitive process. A crucial question, which is directly related to the likelihood of success of this approach is whether the brain cholinergic degeneration in AD is in fact related to any clinically significant extent to the mental deterioration. We suggest that results of our intensive and careful examination of OPCA individuals may have profound implications with respect to 1) the actual role of the brain cholinergic system in human cognition and 2) prospects of successful cholinergic therapy in dementia disorders.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Neurology A Study Section (NEUA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Toronto
Zip Code
M5 1S8
Haycock, John W; Becker, Laurence; Ang, Lee et al. (2003) Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 87:574-85
Morrison, L D; Cao, X C; Kish, S J (1998) Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J Neurochem 71:288-94
Montermini, L; Kish, S J; Jiralerspong, S et al. (1997) Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system. Neurology 49:606-10
Mastrogiacoma, F; Lindsay, J G; Bettendorff, L et al. (1996) Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann Neurol 39:592-8
Bettendorff, L; Mastrogiacomo, F; LaMarche, J et al. (1996) Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1. Mov Disord 11:437-9
Morrison, L D; Smith, D D; Kish, S J (1996) Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 67:1328-31
Mastrogiacomo, F; LaMarche, J; Dozic, S et al. (1996) Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1. Neurodegeneration 5:27-33
Mastrogiacoma, F; Bettendorff, L; Grisar, T et al. (1996) Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. Ann Neurol 39:585-91
Morrison, L D; Kish, S J (1995) Brain polyamine levels are altered in Alzheimer's disease. Neurosci Lett 197:5-8
Zhong, X H; Haycock, J W; Shannak, K et al. (1995) Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Mov Disord 10:10-7

Showing the most recent 10 out of 31 publications